Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioshield Technologies IncfiledCriticalBioshield Technologies Inc
Priority claimed from PCT/US1997/008913external-prioritypatent/WO1997042200A1/en
Publication of NZ329397ApublicationCriticalpatent/NZ329397A/en
he present invention relates to a cascade polymer complex of the general formula 1 A-{X-[Y-(Z-(W-Kw)z)y]s}a A is a nitrogen containing nucleus of base multiplicity a X and Y independently stand for a direct bond or a cascade reproduction unit of reproduction multiplicity x or y Z and W independently stand for a cascade reproduction unit of reproduction multiplicity z or w, K is a radical of a complexing agent a is 2-12 x, y, z and w are 1-4 independently provided that at least two reproduction units are different and that for the product of the multiplicities, 16 ú a.x.y.z.wú64 holds true, and that at least one of cascade reproduction units X, Y, Z and W stands for a 1,4,7,10-tetraazacyclododecane reproduction unit or a 1,4, 8,11-tetraazacyclotetradecane reproduction unit. Also claimed is a pharmaceutical comprising the cascade polymer and use for NMR diagnosis.
NZ329397A1997-05-071997-05-07organosilane compounds and antimicrobial compounds containing a organosilane and polyol reaction product
NZ329397A
(en)
Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered.
New 17-hydroxyiminomethyl-5beta, 14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same.
Process for producing 2,5-diamino-4,6-dichloropyrimidine derivatives protected on the 5-positioned nitrogen atom, as well as pharmaceutical compositions comprising same